| answer text |
<p>In 2021 there were 27 claims related to measles, mumps or rubella (MMR) received
by the Vaccine Damage Payment Scheme (VDPS), one of which is still awaiting a decision
as of 1 February 2024. Additionally in 2021, 616 claims were received relating to
COVID-19, with 42 still awaiting an outcome as of 1 February 2024. 43 claims were
received for all other diseases covered by the Vaccine Damage Payment Act (VDPA) 1979,
and in this category, seven applications were awaiting an outcome as of 1 February
2024.</p><p>In 2022 there were 19 claims related to MMR received by the VDPS, one
of which is still awaiting a decision as of 1 February 2024. Furthermore in 2022,
2723 claims were received relating to COVID-19 with 266 still awaiting an outcome
as of 1 February 2024. 86 claims were received for all other diseases covered by the
VDPA 1979, and of these, 12 applications were still awaiting an outcome as of 1 February
2024.</p><p>In 2023 there were five claims related to MMR received by the VDPS, one
of which is still awaiting a decision as of 1 February 2024. In this same year, 5383
claims were received relating to COVID-19 with 3519 still awaiting an outcome on 1
February 2024. 222 claims were received for all other diseases covered by the VDPA
1979, and of these, 139 applications were still awaiting an outcome as of 1 February
2024.</p>
|
|
